AMED Amedisys PE ratio, current and historical analysis
The PE ratio for Amedisys stock stands at 36.45 as of Feb 4, 2025. This is based on the current EPS of $2.54 and the stock price of $92.59 per share.
AMED PE ratio history
Over the last nine years, the average PE ratio of Amedisys has been 94.68. The current 36.45 PE ratio is 62% below the historical average. Over the past nine years, AMED's PE ratio was at its highest in the Jun 2023 quarter at 1,016, with a price of $91.44 and an EPS of $0.09. The Mar 2023 quarter recorded the bottom point at 21.26, with a price of $73.55 and an EPS of $3.46.
Amedisys PE ratio by year
Maximum annual increase: 53.89% in 2017
Maximum annual decrease: -51.45% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $95.06 | -$0.3 |
| 2022 | 22.89 | -9.35% | $83.54 | $3.65 |
| 2021 | 25.25 | -51.45% | $161.88 | $6.41 |
| 2020 | 52.01 | 23.07% | $293.33 | $5.64 |
| 2019 | 42.26 | 31.36% | $166.92 | $3.95 |
| 2018 | 32.17 | -45.07% | $117.11 | $3.64 |
| 2017 | 58.57 | 53.89% | $52.71 | $0.9 |
| 2016 | 38.06 | N/A | $42.63 | $1.12 |
| 2015 | N/A | N/A | $39.32 | -$0.09 |
| 2014 | 75.26 | N/A | $29.35 | $0.39 |
| 2013 | N/A | N/A | $14.63 | -$3.08 |
| 2012 | N/A | N/A | $11.31 | -$2.79 |
| 2011 | N/A | N/A | $10.91 | -$13.33 |
| 2010 | 8.33 | -14.48% | $33.5 | $4.02 |
| 2009 | 9.74 | -22.7% | $48.6 | $4.99 |
Amedisys PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 38 | 16.74% | $96.51 | $2.54 |
| Jun 2024 | 32.55 | N/A | $91.8 | $2.82 |
| Mar 2024 | N/A | N/A | $92.16 | -$0.63 |
| Dec 2023 | N/A | N/A | $95.06 | -$0.3 |
| Sep 2023 | 934 | -8.07% | $93.4 | $0.1 |
| Jun 2023 | 1,016 | 4,678.93% | $91.44 | $0.09 |
| Mar 2023 | 21.26 | -7.12% | $73.55 | $3.46 |
| Dec 2022 | 22.89 | -12.03% | $83.54 | $3.65 |
| Sep 2022 | 26.02 | 6.68% | $96.79 | $3.72 |
| Jun 2022 | 24.39 | -17.04% | $105.12 | $4.31 |
| Mar 2022 | 29.4 | 16.44% | $172.29 | $5.86 |
| Dec 2021 | 25.25 | 14.15% | $161.88 | $6.41 |
| Sep 2021 | 22.12 | -31.73% | $149.1 | $6.74 |
| Jun 2021 | 32.4 | -24.51% | $244.93 | $7.56 |
| Mar 2021 | 42.92 | -17.48% | $264.79 | $6.17 |
AMED average PE ratio chart
The current PE ratio of AMED is below the 3, 5 and 10-year averages.
AMED PE vs peers
AMED's PE ratio is higher than its peer stocks CHE and CIVI. Amedisys is presently trading at a higher PE ratio (36.45) than its peer group average of 18.23.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CIVI Civitas Resources Inc | 4.9 | $4.86B |
| NHC National Healthcare Corp | 12.58 | $1.57B |
| ADUS Addus HomeCare Corp | 27.58 | $2.23B |
| CHE Chemed Corp | 27.87 | $8.36B |
| AMED Amedisys Inc | 36.45 | $3.03B |
Frequently asked questions
What is Amedisys's PE ratio?
AMED's price to earnings ratio is 36.45 as of Feb 4, 2025.
What is the 3-year average PE ratio for Amedisys (AMED)?
As an average over the last 3 years, AMED stock has a PE ratio of 238.28.
What is the 5-year average PE ratio for Amedisys (AMED)?
As an average over the last 5 years, AMED stock has a PE ratio of 144.82.
What is the highest PE ratio for AMED?
In the last nine years, the Jun 2023 quarter recorded the highest quarterly PE ratio at 1,016.
How does the current PE ratio for AMED compare to its historical average?
AMED's current price to earnings ratio is 62% below its 9-year historical average.
How is AMED's PE ratio calculated (Amedisys PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Feb 4, 2025), Amedisys's stock price is $92.59. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.54. Therefore, Amedisys's P/E ratio for today is 36.45. PE RATIO(36.45) = STOCK PRICE($92.59) / TTM EPS($2.54)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.